Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
130.20
+0.41 (0.32%)
At close: Jul 31, 2026, 4:00 PM EDT
130.31
+0.11 (0.08%)
After-hours: Jul 31, 2026, 7:58 PM EDT

Merck & Co. Revenue

Merck & Co. had revenue of $16.29B in the quarter ending March 31, 2026, with 4.87% growth. This brings the company's revenue in the last twelve months to $65.77B, up 2.89% year-over-year. In the year 2025, Merck & Co. had annual revenue of $65.01B with 1.31% growth.

Revenue (ttm)
$65.77B
Revenue Growth
+2.89%
P/S Ratio
4.89
Revenue / Employee
$876,907
Employees
75,000
Market Cap
321.57B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.01B843.00M1.31%
Dec 31, 202464.17B4.05B6.74%
Dec 31, 202360.12B832.00M1.40%
Dec 31, 202259.28B10.58B21.72%
Dec 31, 202148.70B7.19B17.31%
Dec 31, 202041.52B2.40B6.13%
Dec 31, 201939.12B-3.17B-7.50%
Dec 31, 201842.29B2.17B5.41%
Dec 31, 201740.12B315.00M0.79%
Dec 31, 201639.81B309.00M0.78%
Dec 31, 201539.50B-2.74B-6.48%
Dec 31, 201442.24B-1.80B-4.08%
Dec 31, 201344.03B-3.23B-6.84%
Dec 31, 201247.27B-780.00M-1.62%
Dec 31, 201148.05B2.06B4.48%
Dec 31, 201045.99B18.56B67.66%
Dec 31, 200927.43B3.58B15.00%
Dec 31, 200823.85B-347.70M-1.44%
Dec 31, 200724.20B13.60B128.41%
Dec 31, 200610.59B1.09B11.42%
Dec 31, 20059.51B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson97.93B
AbbVie64.39B
Pfizer63.32B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi54.60B
Novo Nordisk50.57B
Bristol-Myers Squibb Company49.19B
Revenue Rankings